Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Pociredir [Phase 1]

View source ↗

Summary

This Phase 1 study evaluated the safety, tolerability, pharmacokinetics, and pharmacodynamics of Pociredir in people with sickle cell disease; the trial has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Pociredir

Snippet

Sponsor: Fulcrum Therapeutics | Conditions: Sickle Cell Disease, Sickle Cell Anemia | Phase 1 | Status: COMPLETED